The study, published in Nature Cell Biology, focuses on the cell organelle known as centrosome, which organises the network of microtubules that serves as the cell’s skeleton.
Post-doctoral fellow Jelena Urosevic receives funding for two years.
24 baccalaureate students in Catalonia selected from among 400 start a one-year programme devoted to life sciences that aims to nurture passion for science.
The jury, chaired by Carlos López-Otín, endorses the research on bone metastasis that led to the set up of the spin-off Inbiomotion.
Researchers have developed a platform that compiles all the atomic data, previously stored in diverse databases, on protein structures and protein interactions for eight organisms of relevance. They apply a singular homology-based modelling procedure.
Given the high reliability of the results it produces, the new tool, Interactome3D, has received the endorsement of Nature Methods, the journal that has published the project.
IRB Barcelona and the BBVA Foundation organize an international conference in Barcelona on biostatistics, the science that helps biomedicine explain biological phenomena, make medical predictions, and design robust experiments.
The workshop is organized by IRB Barcelona as part of the CatalunyaCaixa Foundation's Professors and Science programme.
Its aim is to improve science teaching in schools and increase science as a vocation among students.
Iproteos, a spin-off from IRB Barcelona and the University of Barcelona, has been awarded the '2nd RedEmprendia University to Business Spin-off Prize 2012’, which was presented on Wednesday 28 November during the international ‘RedEmprendia Spin2012’ conference held in Madrid.
The study, published in PNAS, opens the way for large-scale screenings to identify new targets for cancer therapy.
Scientists at IRB Barcelona present a model to demonstrate the correlation between genomic instability and cancer.
The team led by IRB Barcelona’s David Rossell and Patrick Aloy and by Anaxomics Biotech ranked among the best in the world for diagnosing and classifying patients in a blind test for four diseases.